Completed PHASE3 INTERVENTIONAL 2-arm NCT02232763

Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular Proteinuria

A Prospective, Randomized, Cross-over Study Evaluating the Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular Proteinuria

Sponsor: Ministry of Food and Drug Safety, Korea

Conditions Proteinuria

Interventions Losartan Placebo

Updated 8 times since 2017 Last updated: Oct 8, 2018 Started: Sep 30, 2014 Primary completion: Jul 31, 2016 Completion: Sep 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Proteinuria, this trial is completed. The trial is conducted by Ministry of Food and Drug Safety, Korea and has accumulated 8 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Nov 2018 — Jan 2021 [monthly]

Completed PHASE3

Status: Active Not Recruiting → Completed

▶ Show 3 earlier versions

Jun 2018 — Nov 2018 [monthly]

Active Not Recruiting PHASE3
Aug 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE3

Status: Unknown Status → Active Not Recruiting
Jan 2017 — Aug 2017 [monthly]

Unknown Status PHASE3

First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ministry of Food and Drug Safety, Korea
Seoul National University Hospital

Data source: Seoul National University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea